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Background: Pain and natural rewards such as food elicit different behavioral effects. Both pain and rewards, however,
have been shown to alter synaptic activities in the nucleus accumbens (NAc), a key component of the brain reward
system. Mechanisms by which external stimuli regulate plasticity at NAc synapses are largely unexplored. Medium spiny
neurons (MSNs) from the NAc receive excitatory glutamatergic inputs and modulatory dopaminergic and cholinergic
inputs from a variety of cortical and subcortical structures. Glutamate inputs to the NAc arise primarily from prefrontal
cortex, thalamus, amygdala, and hippocampus, and different glutamate projections provide distinct synaptic and
ultimately behavioral functions. The family of vesicular glutamate transporters (VGLUTs 1–3) plays a key role in the
uploading of glutamate into synaptic vesicles. VGLUT1-3 isoforms have distinct expression patterns in the brain, but the
effects of external stimuli on their expression patterns have not been studied.
Results: In this study, we use a sucrose self-administration paradigm for natural rewards, and spared nerve injury
(SNI) model for chronic pain. We examine the levels of VGLUTs (1–3) in synaptoneurosomes of the NAc in these two
behavioral models. We find that chronic pain leads to a decrease of VGLUT1, likely reflecting decreased projections
from the cortex. Pain also decreases VGLUT3 levels, likely representing a decrease in projections from GABAergic,
serotonergic, and/or cholinergic interneurons. In contrast, chronic consumption of sucrose increases VGLUT3 in the
NAc, possibly reflecting an increase from these interneuron projections.
Conclusion: Our study shows that natural rewards and pain have distinct effects on the VGLUT expression pattern in
the NAc, indicating that glutamate inputs to the NAc are differentially modulated by rewards and pain.
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Natural rewards and pain are represented in the brain
with opposite hedonic values. Chronic administration of
rewards leads to seeking and craving [1]. Pain, on the
other hand, triggers avoidance behavior, and chronic
pain can even lead to depression and anxiety [2]. The
molecular basis for the behavioral changes observed
after chronic presentation of natural reward and pain,
however, remains incompletely understood. The nucleus
accumbens (NAc) is a key component of brain reward* Correspondence: Jing.wang2@nyumc.org
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reproduction in any medium, provided the orcircuitry [1,3]. Recent works from our and other labs
show that medium spiny neurons (MSNs) in the NAc
undergo synaptic modifications in the presence of natural
rewards or drugs of addiction [4-7], and that synaptic
plasticity in the NAc modulates craving for natural
rewards or drugs of abuse [6,8]. We have recently shown,
in particular, that in the presence of a natural reward such
as sucrose, glutamate signaling in the NAc is augmented
through synaptic incorporation of calcium permeable
AMPA receptors (CPARs) [7]. At the same time, the NAc
has also been shown by human imaging and animal
studies to be activated by pain [9,10]. Furthermore, there
is evidence that activation of the NAc in pain states is
involved in avoidance behaviors. Thus, the NAc is antd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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behavioral plasticity.
The NAc receives afferent inputs from multiple cortical
and subcortical structures, including the prefrontal cortex
(PFC), thalamus, hippocampus, amygdala, and ventral
tegmental area (VTA) [3]. The PFC, thalamus, hippocam-
pus, and amygdala provide key glutamate inputs to the
NAc, whereas the VTA is the main source for dopamine.
A complex interplay of glutamate and dopamine inputs
modulates the synaptic functions of the NAc [11-15].
There is emerging evidence that appetitive and aversive
stimuli provide distinct dopaminergic inputs to the NAc
[16,17]. However, the glutamatergic inputs to the NAc
have not been well characterized in the presence of natural
rewards or pain.
The accumulation of presynaptic glutamate in secretory
vesicles is mediated by vesicular glutamate transporters
(VGLUTs). VGLUTs (1–3) are a family of glutamate trans-
port molecules, and these transporters control glutamate
release from presynaptic neurons [18,19]. The levels of
VGLUT expression have been correlated with levels of
glutamate at the synaptic cleft [18]. Members of the
VGLUT family also have distinct expression patterns.
VGLUT1 and VGLUT2 are expressed in glutamatergic
neurons in a complementary manner [20,21]. In the brain,
VGLUT1 is primarily found in the cerebral cortex,
hippocampus, and cerebellar cortex nuclei [21-25]. In
contrast, VGLUT2 is mainly expressed in the thalamus,
brainstem and deep cerebellar nuclei [21-23,25]. In
addition, VGLUT2 has been found in dopaminergic
neurons, in particular, in dopaminergic neurons from
the VTA [26-29]. A third member of the VGLUT family,
VGLUT3, is found in serotonergic neurons in the raphe
nuclei and a subset of GABAergic interneurons in the
cortex and hippocampus [20,30,31]. This primarily
non-glutamatergic distribution of VGLUT3 suggests
that it may in fact be a co-transporter of glutamate and
other inhibitory or modulatory molecular signals such
as GABA and serotonin [32]. In particular, VGLUT3 is
also expressed on cholinergic interneurons in the NAc
[33,34]. These cholinergic interneurons have been
shown to play a critical role for the function of the
NAc [35-37], and VGLUT3 likely regulates the co-release
of acetylcholine and glutamate to influence the synaptic
function in these neurons [33,34].
Because of the distinct expression pattern of theVGLUTs
1–3, these proteins can serve as presynaptic markers to
understand glutamate inputs to the NAc under conditions
of rewards or pain. We have developed a sucrose self-
administration paradigm in rats to model chronic
natural rewards, and we have recently shown that this
paradigm induces psychomotor hyperactivity, a behavioral
phenotype that is indicative of reward seeking [7]. In
addition, we found that this paradigm results in theformation of CPARs, an important form of synaptic
modification in the NAc. Transmission through these
newly formed receptors, in turn, regulates reward seeking
behaviors [7]. At the same time, we have also developed
spared nerve injury (SNI) to model chronic pain in rats,
and we have shown that this model leads to depression-
like behaviors in addition to sensory allodynia [38]. In the
current study, we examine VGLUTs levels in the NAc
using these two rat models. We find that chronic pain
decreases VGLUT1 and 3 levels, whereas repeated sucrose
intake causes an increase in VGLUT3. These data suggest
that pain causes a decrease in cortical inputs to the NAc.
Meanwhile, co-release of glutamate with GABA, sero-
tonin, and/or acetylcholine at NAc synapses is potentially
decreased by chronic pain, but increased by natural
rewards.
Results
Chronic pain decreases VGLUT1 and VGLUT3 expression
in the NAc
We used the SNI model, a peripheral nerve injury model
for chronic neuropathic pain in adult male rats [38]. In
this model, we surgically resected common peroneal and
tibial branches of the sciatic nerve, leaving the sural
nerve intact. 3 days after SNI, rats experienced abnormal
hypersensitivity to mechanical and cold stimuli (Figure 1A
and 1B), classic sensory indices for pain. Sensory hyper-
sensitivity after SNI was chronic, persisting for at least 14
days (p < 0.0001) [38]. In contrast, control rats which
underwent sham operation did not show this sensory
hypersensitivity.
To examine the expression patterns of different VGLUTs
in the NAc in the chronic pain state, we used Western
blot analysis to measure the protein levels of VGLUT1-3
from the NAc in SNI- or sham-treated rats. We isolated
synaptoneurosome fractions from the NAc in these rats
14 days after surgery. Synaptoneurosome fractions contain
both pre- and postsynaptic terminals. As over 90% of
neurons in the NAc are MSNs, these fractions likely
reflect synaptic terminals at MSN synapses. In this case,
synaptoneurosome fractions were used to assess the
presynaptic expression of VGLUTs. We observed a 30%
decrease in the level of VGLUT1 in SNI-treated ani-
mals (Figure 2A, n=14-15, p < 0.05). Because VGLUT1
is predominantly expressed in cortical structures such
as cerebral cortex, hippocampus, and cerebellar nuclei,
our data indicate that chronic pain causes a decrease in
the glutamate release from these regions. The level of
VGLUT2, however, remained unchanged (Figure 2B,
n=15, p > 0.05), suggesting that summed glutamate in-
puts from thalamus and brainstem to the NAc, mainly
mediated by VGLUT2, are likely unaltered in the pain
state at a gross biochemical level. Finally, VGLUT3
levels also showed a 20% decrease in chronic pain
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Figure 1 SNI Causes Mechanical and Cold Hypersensitivity After Surgery. (A) SNI-operated rats developed mechanical hypersensitivity after
surgery. Two-way ANOVA with repeated measures, followed by Bonferroni post-test, n = 6, p < 0.0001. (B) Rats developed cold hypersensitivity
after SNI. n = 6, p < 0.0001. Error bars show mean and s.e.m.
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creased capacity for glutamate co-release onto the
MSNs in the NAc from non-glutamatergic neurons.
Repeated sucrose ingestion increases VGLUT 3 expression
in the NAc
Next we examined VGLUT expressions in the presence
of chronic consumption of sucrose, a natural reward.
We recently developed a sucrose ingestion paradigm to
model the effects of a natural, orosensory reward (Figure 3)
[7]. Here, adult male rats were transported to a test
room on three consecutive days to acclimate to the test
environment. Subsequently, the rats were given 5 minutes
access to 25% sucrose solution for 7 consecutive days.
During each of these conditioning days, rats were exposed











































Figure 2 Chronic Pain Causes a Selective Decrease in VGLUT1 and VG
subunits in the synaptoneurosomes of NAc. Student’s t test, n=15, p < 0.05. (B
of the NAc. n = 15, p > 0.05. (C) SNI caused a decrease in VGLUT3 subunits in
to values in the sham group. Error bars show mean and s.e.m.(control) for 5 min. This brief, non-contingent access
to a highly palatable (sucrose) solution allowed us to
investigate the cumulative effect of repeated consumption
of a natural reward (Figure 3). We recently reported that
this paradigm results in psychomotor hyperactivity, a
behavioral trait indicative of reward seeking, as well as
synaptic modifications in the NAc [7].
Using this sucrose ingestion model, we isolated the
synaptoneurosome fractions of rats in the sucrose group
as well as rats in the water (control) group. We found
that after 7 days of sucrose consumption, there was min-
imal difference in the synaptoneurosomal expression of
VGLUT1 levels in the sucrose group and the control
group (Figure 4A, n = 8-9, p > 0.05). This is in contrast
to our finding of decreased VGLUT1 expression in rats





















LUT3 Expression in the NAc. (A) SNI caused a decrease in VGLUT1
) SNI caused no changes in VGLUT2 subunits in the synaptoneurosomes








7 Days of sucrose (or water) consumption
Figure 3 Sucrose Ingestion Paradigm. Adult male rats were transported to a test room for 3 consecutive days. The rats were then placed in a
chamber for the next 7 days, exposed to bottles containing either 25% sucrose or water (control) for five min on each of these days.
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group compared with control group (Figure 4B, n = 11).
However, this increase was not statistically significant
(p > 0.05). Interestingly, we observed a significant in-
crease in the level of VGLUT3 (~40%) in the sucrose
group (Figure 4C, n =10, p < 0.05). These data suggest
that an increase in the transport of glutamate to the
NAc from primarily non-glutamatergic neurons may










































Figure 4 Repeated Sucrose Ingestion Causes a Selective Increase in V
caused no changes in VGLUT1 subunits in the synaptoneurosomes of NAc.
causes an increased trend for the level of VGLUT2 subunits in the synapton
sucrose caused an increase in VGLUT3 subunits in the synaptoneurosomes
control group. Error bars show mean and s.e.m.we found in the chronic pain model, where a decrease of
VGLUT3 was observed in SNI-treated rats.
Discussion
In this study, we examine how natural rewards and pain
alter the expression of VGLUTs in the NAc. We find
that levels of VGLUT1 and VGLUT3 are decreased with
chronic pain, and that VGLUT3 level is increased with
chronic administration of natural rewards. These results-65 kDa
-55 kDa-55 kDa
-56 kDa























GLUT3 Expression in the NAc. (A) Repeated ingestion of sucrose
Student’s t test, n = 8-9, p > 0.05. (B) Repeated ingestion of sucrose
eurosomes of the NAc. n =11, p > 0.05. (C) Repeated ingestion of
of the NAc. n =10, p < 0.05. Data were normalized to values in the
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circuitry resulting from induction of appetitive and
aversive states.
Here we use a behavioral protocol that mimics repeated
natural reward consumption [7]. In a previous report,
we used this model to show that sucrose consumption
increases psychomotor hyperactivity. Psychomotor hyper-
activity has been used as an index for addiction-like
behaviors, and thus our model provides a predictable
behavioral response to chronic consumption of a natural
reward. In addition, using this model we have previously
shown that chronic sucrose consumption leads to the
formation of CPARs at the postsynaptic sites of MSNs. In
our current study, we use this same behavioral paradigm
for natural rewards to assess presynaptic changes in the
NAc [7]. At the same time, we compare these presynaptic
changes occurring in response to natural rewards with
changes that occur in a chronic pain state, a behavioral
condition with contrasting hedonic value.
VGLUT1 is primarily expressed in cortical structures,
and it has been shown that the NAc receives gluta-
matergic inputs from the PFC and hippocampus in
particular [3]. Interplay between hippocampal and PFC
glutamate inputs is thought to provide synaptic plasticity
in the MSNs to regulate reward learning [39,40]. Our
finding that VGLUT1 level is decreased by chronic pain
indicates that there may be a diminution of these afferent
inputs. This decrease can be the result of decreased
expression, altered connectivity, or loss of afferent fibers.
Previous reports of grey matter loss in the PFC in chronic
pain states suggest the latter possibility [9,41]. On the
other hand, the level of VGLUT1 is unaltered in the
chronic sucrose administration model. Cortical inputs are
well known to regulate reward seeking behaviors [8]. A
lack of change in VGLUT1 levels in our study on natural
rewards suggests that this top down control may be
preserved in the presence of natural rewards.
In contrast to VGLUT1, VGLUT2 is primarily expressed
in subcortical structures [20,21]. Whereas the brainstem
provides a minor afferent input to the NAc, the thalamus
is a major source of glutamate for the NAc [42,43]. In our
study, there is an increased trend for VGLUT2 with
repeated sucrose consumption, but this trend is not statis-
tically significant. In our model of natural reward, sucrose
likely stimulates the orosensory circuit, and the thalamus
is a key locus in this circuit. The thalamo-striatal circuit is
also known to play an important role in reinstatement of
reward learning [44], and thalamic projections have been
shown to modify dopaminergic inputs to the NAc in the
presence of natural rewards. At the same time, however,
VGLUT2 has also been found in dopaminergic neurons
from the VTA that project to the NAc [26-29]. Its pres-
ence in these neurons has been proposed to allow the re-
lease of glutamate from VTA dopamine neurons [45].This synergy between glutamate and dopamine signaling
may be critical for the plasticity of postsynaptic AMPA
receptors [46]. In our study, VGLUT2 appears to be
increased in the NAc with repeated sucrose ingestion.
This increased trend, while not statistically significant,
nevertheless suggests that orosensory rewards may either
strengthen thalamo-striatal connectivity and/or promote
the co-release of glutamate and dopamine. In contrast,
VGLUT2 levels are unaltered in the pain state.
Whereas VGLUT1 and 2 are expressed in typical glu-
tamatergic neurons, VGLUT3 is often expressed on se-
rotonergic, GABAergic, or cholinergic neurons and may
regulate the co-release of glutamate and serotonin,
GABA, or acetylcholine from presynaptic terminals [32].
In the striatum, VGLUT3 is highly expressed in the
cholinergic interneurons [33,34]. Although these inter-
neurons comprise of a minority of the neuronal popula-
tion in the NAc, their inputs to the MSN have been
shown to regulate food satiety and addiction to drugs
[47-49]. We find here that in the NAc, VGLUT3 is
increased in rats that consume sucrose repeatedly, and
decreased in rats that have chronic pain. In the NAc,
VGLUT3 is involved in the co-release of glutamate from
these cholinergic neurons [33,34]. Thus, there are two
possible interpretations of our data. First, the change in
VGLUT3 levels may represent only a change in the
extent of co-release of glutamate, without a concurrent
change in acetylcholine release. In this scenario, there
may be a de-coupling of glutamate and acetylcholine
release from these interneurons. This may serve as a
mechanism to selectively control glutamate outputs lo-
cally from these neurons without compromising their
cholinergic outputs. Cholinergic outputs from these in-
terneurons have been shown to modulate the excitability
of MSNs and regulate their responsiveness to additional
dopaminergic and glutamatergic inputs [35-37]. This de-
coupling mechanism allows the preservation of this cho-
linergic tone and its subsequent regulation of dopamine
and glutamate responsiveness of the MSNs. In this case,
pain may only decrease glutamate input in the MSNs lo-
cally, but modulatory cholinergic inputs are preserved,
allowing continued cholinergic gating of inputs from
other neuronal sources. Likewise, natural rewards may
selectively increase glutamate inputs to the MSNs, with-
out changes in the cholinergic tone in the NAc. A sec-
ond possible interpretation of our VGLUT3 data is that
there is an overall alteration in the presynaptic inputs
from these cholinergic interneurons, and both acetylcho-
line and glutamate release are simultaneously modified
by pain or natural reward. In this scenario, the overall
neuronal activities of these cholinergic neurons can be
modified by the hedonic state of the animal. For example,
in the pain state, in addition to a decrease in excitatory
glutamate inputs, a reduction of cholinergic inputs may
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to dopamine and glutamate inputs from other brain re-
gions as well. In either case, innervation from cholinergic
interneurons responds to the hedonic value, where nat-
ural rewards increase the capacity for glutamate release,
and pain decreases it. Finally, VGLUT3 is also expressed
in serotonergic neurons in the raphe nuclei and a subset
of GABAergic interneurons in the cortex and hippocam-
pus [20,30,31]. Thus, it is also possible that alterations in
VGLUT3 levels observed in our study correspond to
changes in inputs from these more distant neuronal
populations. Regardless of the exact source of VGLUT3,
this opposing expression pattern in pain vs. reward state
signals a novel form of synaptic control in the NAc.
Conclusion
We find that chronic consumption of sucrose, a natural
reward, increases VGLUT3 expression in the NAc. Chro-
nic pain, however, decreases VGLUT1 and VGLUT3
levels. These results suggest that natural rewards and pain
have distinct but important effects on the glutamatergic
inputs to the NAc. This study provides the foundation for




All procedures in this study were approved by the New
York University School of Medicine Institutional Animal
Care and Use Committee (IACUC) as consistent with
the National Institute of Health (NIH) Guide for the
Care and Use of Laboratory Animals (publication number
85–23) to ensure minimal animal use and discomfort.
Male Sprague–Dawley rats were purchased from
Taconic Farms, Albany, NY and kept in the NYU
Langone Medical Center’s Central Animal Facility, with
controlled humidity, room temperature, and 12-h (6:30
AM to 6:30 PM) light–dark cycle. Food and water were
available ad libitum. Animals arrived to the animal facility
at 300 to 350 grams and were given on average 10 days to
adjust to the new environment prior to the onset of any
experiments.
Spared nerve injury (SNI) surgery
The Spared Nerve Injury (SNI) surgery was previously
described in detail [38]. Briefly, under Isoflurane
anesthesia (1.5 to 2%), the skin on the lateral surface of
the right thigh of the rat was incised and a section made
through the biceps femoris muscle to expose three
branches of the sciatic nerve: sural, common peroneal and
tibial nerves. The common peroneal and tibial nerves were
tied with non-absorbent 5.0 silk sutures at the point of
trifurcation. The nerves were then cut distal to the knot,
and about 3 to 5 mm of the distal ends were removed. Insham surgeries (control), above nerves were dissected but
not cut. Muscle layer was then sutured closed with ab-
sorbent 4.0 antibacterial sutures, while skin was stapled.
Staples were removed prior to behavioral testing. Animals
were sacrificed 14 days after SNI or sham surgery.Sucrose self-administration paradigm
The sucrose self-administration procedure was performed
as previously reported. Rats were transported to the test
room 3 consecutive days for 2 h/day in their home cages.
On the fourth day, after 15-min in the chamber, a bottle
with a bead stopper was introduced through the top of the
chamber and stabilized. This bottle was introduced for 5
min, and rats were allowed to drink ad libitum, and each
rat consumed at least 1 g of sucrose by the third session.
The bottle was removed from the top of the chamber after
5-min, and the rats remained in the chamber for an add-
itional 15-min after bottle removal. This procedure was
repeated identically for 7 consecutive days. On the day of
sacrifice, rats were decapitated by guillotine, and tissue
samples were collected on ice.Subcellular fractionation and Western blotting
Rats were deeply anesthetized with isoflurane (5%) and
decapitated immediately. Brains were quickly removed
and nucleus accumbens were collected on ice. Whole
cell and synaptosome fractions were prepared as described
previously [7]. To prepare synaptoneurosome fractions,
nucleus accumbens samples were homogenized in an
ice-cold solution A (0.32 M sucrose, 1 mM NaHCO3, 1
mM MgCl2, 0.5 mM CaCl2, 0.1 mM PMSF and 1×
Complete Protease Inhibitors (Roche Applied Science).
Homogenates were centrifuged at 4,000 rpm for 10 min.
The supernatant was collected and the pellet re-
homogenized in solution A and centrifuged again at 3,000
rpm for 10 min. Combined supernatants were subjected
to a second centrifugation at 3,000 rpm for 10 min. Super-
natants were then spun at 14,000 rpm for 30 min. Pellet
was resuspended in solution B (0.32 M sucrose, 1 mM
NaHCO3) and homogenized. Homogenate was layered on
top of a 5 mL 1 M sucrose and 1.2 M sucrose gradient
and centrifuged at 30,000 rpm for 2 hours. Purified synap-
tosomes were collected at the 1 M and 1.2 M sucrose
interface, suspended in solution B and centrifuged at
40,000 rpm for 45 min. Synaptosomal pellets were
resuspended in 25 mM TRIS with 4% SDS. Equal amounts
of fractions (5–10 μg) were loaded on SDS-PAGE gels
and analyzed by Western blot as previously described.
Fractions were analyzed by Western blot on SDS-PAGE
gels as described previously [48]. The following antibodies
were used: VGLUT1 (1:1,000, Millipore), VGLUT2
(1:1,000, Millipore), VGLUT3 (1:500, Millipore) and
tubulin (1:30,000, Sigma).
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Mechanical hypersensitivity test
A traditional Dixon up-down method with von Frey fila-
ments was used to measure mechanical hypersensitivity as
described previously [38]. In brief, rats were individually
placed into plexiglass chambers over a mesh table and
acclimated for 20 min before the onset of examination.
Beginning with 2.55 g, von Frey filaments in a set with
logarithmically incremental stiffness (0.45, 0.75, 1.20, 2.55,
4.40, 6.10, 10.50, 15.10 g) were applied to the lateral 1/3 of
right paws (in the distribution of the sural nerve) of rats.
50% withdrawal threshold was calculated as described
previously [38].
Cold hypersensitivity test
Animals were individually placed into plexiglass chambers
as above and acclimated for 20 min. A drop of acetone
was applied to the lateral plantar surface of the paws
(in the distribution of the sural nerve). As previously
described [38], the following scoring system was applied.
0: no visible response or startle response lasting < 0.5
second; 1: paw withdrawal lasting < 5 seconds; 2: with-
drawal lasting 5 to 10 seconds, +/− licking of the paws; 3:
prolonged repetitive withdrawal lasting > 10s. Acetone
was applied 5 times to each paw, and an average score was
calculated. Cold hypersensitivity tests were typically done
after mechanical allodynia tests on the same day, and
observers were blinded to the test conditions.
Data analysis and statistics
For Western blots, unpaired two-tailed Student’s t tests
were used to analyze the proteins levels in SNI- versus
sham-treated rats and to analyze water vs. sucrose con-
suming rats. The results of behavioral experiments were
given as mean ± SEM. For mechanical hypersensitivity, a
two-way ANOVA with repeated measures, followed by
post hoc multiple pair-wise comparison Bonferroni tests
was used to compare the 50% withdrawal threshold of
SNI- and sham-treated rats. Cold hypersensitivity was
analyzed using a two-way ANOVA with repeated mea-
sures, followed by post hoc multiple pair-wise compari-
son Bonferroni tests. For all tests, a p value < 0.05 was
considered statistically significant. All data were analyzed
using GraphPad Prism Version 5 software (GraphPad,
La Jolla, CA).
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